Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
05/01/1996 | EP0709099A2 An aqueous nasal suspension comprising cyclodextrin |
05/01/1996 | EP0709087A1 Medicinal and/or nutritional microcapsules for oral administration |
05/01/1996 | EP0708662A1 Injectable polysaccharide-cell compositions |
05/01/1996 | EP0708661A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
05/01/1996 | EP0708660A1 Prodrugs of protein tyrosine kinase inhibitors |
05/01/1996 | EP0708646A1 Use of vitamin e tocopheryl derivatives in ophthalmic compositions |
05/01/1996 | EP0708643A1 Transdermal melatonin delivery system |
05/01/1996 | EP0708637A1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
05/01/1996 | EP0586694B1 Process and device for low-emission spraying |
05/01/1996 | EP0519926B1 Transdermal system |
05/01/1996 | EP0497956B1 Controlled release formulations |
05/01/1996 | EP0467954B1 Preparation of liposome and lipid complex compositions |
05/01/1996 | EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates |
05/01/1996 | CN1121694A Cyclosporin-containing powder composition |
05/01/1996 | CN1121692A Composition containing cholestyramine and method of producing the same |
05/01/1996 | CN1121691A Stabilized injection and method of stabilizing injection |
05/01/1996 | CN1121688A Stable, ingestable and absorbable NADH and NADPH therapeutic compositions |
04/30/1996 | US5512648 Polyamide resin-protide conjugate, preparation and uses |
04/30/1996 | US5512547 Pharmaceutical composition of botulinum neurotoxin and method of preparation |
04/30/1996 | US5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same |
04/30/1996 | US5512329 Substrate surface preparation |
04/30/1996 | US5512306 Smoking substitute |
04/30/1996 | US5512302 Pharmaceutical process using starch |
04/30/1996 | US5512301 Collagen-containing sponges as drug delivery compositions for proteins |
04/30/1996 | US5512297 Sustained release heterodisperse hydrogel systems for insoluble drugs |
04/30/1996 | US5512295 Synthetic liposomes for enhanced uptake and delivery |
04/30/1996 | US5512292 Transdermal contraceptive formulations methods and devices |
04/30/1996 | US5512289 Spermicidal anti-viral lubricant composition and method of using same |
04/30/1996 | US5512278 Ointment base useful for pharmaceutical preparations |
04/30/1996 | US5512270 Respiratory system disorders, parkinson's disease, gastrointestinal disorders |
04/30/1996 | US5512268 Polymeric shells for medical imaging prepared from synthetic polymers, and methods for the use thereof |
04/30/1996 | US5512200 Low pH Acidic Compositions |
04/30/1996 | US5512092 Method for preparing aqueous emulsion for coating solid pharmaceutical preparations |
04/30/1996 | CA2026278C Use of alkylphosphoric acid compounds for combatting psoriasis disorders |
04/25/1996 | WO1996012190A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
04/25/1996 | WO1996012019A2 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family |
04/25/1996 | WO1996011953A1 N-terminally chemically modified protein compositions and methods |
04/25/1996 | WO1996011712A2 Cell-specific gene delivery vehicles |
04/25/1996 | WO1996011711A1 Saponin preparations and use thereof in iscoms |
04/25/1996 | WO1996011710A1 External preparation for nail ringworm |
04/25/1996 | WO1996011706A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
04/25/1996 | WO1996011705A1 Formulations comprising therapeutically-active proteins or polypeptides |
04/25/1996 | WO1996011704A1 A pharmaceutical formulation comprising a growth hormone and leucine |
04/25/1996 | WO1996011703A1 A pharmaceutical formulation comprising a growth hormone and isoleucine |
04/25/1996 | WO1996011702A1 A pharmaceutical formulation comprising a growth hormone and valine |
04/25/1996 | WO1996011699A1 Pharmaceutical composition of botulinum neurotoxin and method of preparation |
04/25/1996 | WO1996011694A2 AROMATIC COMPOSITION BASED ON OLIBANAM COMBINED WITH A SYNERGIC AGENT (e.g. EUCALYPTOL, BARNEOL, ZINC, SALT, COPPER, SALT) AND USE THEREOF |
04/25/1996 | WO1996011693A1 Dermatosis remedy |
04/25/1996 | WO1996011687A1 Sabeluzole oral suspensions |
04/25/1996 | WO1996011675A2 Medicinal and/or nutritional microcapsules for per os administration |
04/25/1996 | WO1996011672A1 Lyophilized preparation providing reversibly thermogelling water-base medicinal composition |
04/25/1996 | WO1996011670A1 Ether lipid liposomes and their therapeutic use |
04/25/1996 | WO1996011669A1 Lyophilizate of lipid complex of water insoluble camptothecins |
04/25/1996 | WO1996011667A1 Bifunctional cosmetic and/or dermatological ingredients, uses thereof, preparation method therefor, and compositions containing said ingredients |
04/25/1996 | CA2472085A1 N-terminally chemically modified protein compositions and methods |
04/25/1996 | CA2202680A1 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
04/25/1996 | CA2202622A1 Use of protease inhibitors and protease vaccines to protect animals from flea infestation, and flea protease proteins, nucleic acid molecules and uses thereof |
04/25/1996 | CA2202612A1 Formulations comprising therapeutically-active proteins or polypeptides |
04/25/1996 | CA2202554A1 Aromatic composition on olibanam combined with a synergic agent (e.g. eucalyptol, barneol, zinc, salt, copper, salt) and use thereof |
04/25/1996 | CA2202533A1 Her4 human receptor tyrosine kinase |
04/25/1996 | CA2202478A1 Cell-specific gene delivery vehicles |
04/25/1996 | CA2199179A1 Ether lipid liposomes and their therapeutic use |
04/24/1996 | EP0707857A1 Chitosan oligomer derivatives, labelled with Gd-DTPA, for use as magnetic resonance contrast agents |
04/24/1996 | EP0707853A1 Muscle relaxant pharmaceutical compositions |
04/24/1996 | EP0707848A1 Solid pharmaceutical composition comprising an excipient capable of binding water |
04/24/1996 | EP0707847A1 Ketoprofen liposomes |
04/24/1996 | EP0707846A2 A method for synthesizing a liposome |
04/24/1996 | EP0707596A1 Conjugation-stabilized polypeptide compositions |
04/24/1996 | EP0707489A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
04/24/1996 | EP0707478A1 Improved nicotine lozenge and therapeutic method for smoking cessation |
04/24/1996 | EP0707475A1 Extended release, film-coated tablet of astemizole and pseudoephedrine |
04/24/1996 | EP0707473A1 Oral pharmaceutical compositions comprising a protein or peptide, an antibody and polymeric beads |
04/24/1996 | EP0707471A1 Novel therapeutic drug delivery systems |
04/24/1996 | EP0707446A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
04/24/1996 | EP0662819B1 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof |
04/24/1996 | EP0649301B1 Cold cream used in oxidative hair dyes and hair bleaching compositions |
04/23/1996 | US5510466 Scavenger receptor protein and antibody thereto |
04/23/1996 | US5510418 Glycosaminoglycan-synthetic polymer conjugates |
04/23/1996 | US5510392 Polyalpha olefins for food and pharmaceutical applications |
04/23/1996 | US5510391 Method of treating blood vessel disorders of the skin using vitamin K |
04/23/1996 | US5510387 Antimicrobial interferon-inducing medicament |
04/23/1996 | US5510327 Containing tumor cytotoxic factor, basic amino acid or salt thereof, organic or inorganic salt |
04/23/1996 | US5510250 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses |
04/23/1996 | US5510240 Method of screening a peptide library |
04/23/1996 | US5510121 Containing a synthetic hydrophilic polymer |
04/23/1996 | US5510103 Physical trapping type polymeric micelle drug preparation |
04/22/1996 | CA2160819A1 Diagnostic imaging agent |
04/21/1996 | CA2160739A1 Ketoprofen liposomes |
04/18/1996 | WO1996011277A1 Microorganisms as therapeutic delivery systems |
04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
04/18/1996 | WO1996011205A1 Peptide nucleic acid conjugates |
04/18/1996 | WO1996011055A1 Method of coating particles |
04/18/1996 | WO1996011054A2 Process for the preparation of microspheres and microspheres made thereby |
04/18/1996 | WO1996011022A1 DRUG COMPOUNDING INGREDIENTS COMPRISING N-SUBSTITUTED-o-TOLUIDINE DERIVATIVE AND PERCUTANEOUSLY ABSORBABLE PREPARATION |
04/18/1996 | WO1996011021A2 Treatment of tissues to reduce subsequent response to injury |
04/18/1996 | WO1996011018A1 Stable, aqueous alfa interferon solution formulations |
04/18/1996 | WO1996011013A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
04/18/1996 | WO1996011012A1 Hematopoietic cell l-selectin ligand (hll) and therapeutics thereof |
04/18/1996 | WO1996011008A1 Administration of a 27-hydroxycholesterol or prodrug thereof as an anti-cancer agent |
04/18/1996 | WO1996011007A1 Parenteral pharmaceutical compositions containing gf120918a |